-
公开(公告)号:EP2373163A1
公开(公告)日:2011-10-12
申请号:EP09837920.9
申请日:2009-12-17
申请人: Genentech, Inc. , The Walter and Eliza Hall Institute of Medical Research , Abbott Laboratories
发明人: BAELL, Jonathan, Bayldon , BUI, Chinh, Thien , COLMAN, Peter , CZABOTAR, Peter , DUDLEY, Danette, A. , FAIRBROTHER, Wayne, J. , FLYGARE, John, A. , LESSENE, Guillaume, Laurent , NDUBAKU, Chudi , NIKOLAKOPOULOS, George , SLEEBS, Brad, Edmund , SMITH, Brian, John , WATSON, Keith, Geoffrey , ELMORE, Steven, W. , HASVOLD, Lisa, A. , PETROS, Andrew, M. , SOUERS, Andrew, J. , TAO, Zhi-Fu , WANG, Le , WANG, Xilu , DESHAYES, Kurt
IPC分类号: A01N43/00
CPC分类号: C07D417/14 , C07D471/06 , C07D473/00 , C07D487/04 , C07D495/04 , C07D513/04 , C07D513/06
摘要: In one aspect, the present invention provides for a compound of Formula I; in which the variable X
1a , X
1b , X
1c , X
1d , Q, A, R
1 , B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-x
L proteins.-
公开(公告)号:EP2373163B1
公开(公告)日:2015-06-10
申请号:EP09837920.9
申请日:2009-12-17
发明人: BAELL, Jonathan, Bayldon , BUI, Chinh, Thien , COLMAN, Peter , CZABOTAR, Peter , DUDLEY, Danette, A. , FAIRBROTHER, Wayne, J. , FLYGARE, John, A. , LESSENE, Guillaume, Laurent , NDUBAKU, Chudi , NIKOLAKOPOULOS, George , SLEEBS, Brad, Edmund , SMITH, Brian, John , WATSON, Keith, Geoffrey , ELMORE, Steven, W. , HASVOLD, Lisa, A. , PETROS, Andrew, M. , SOUERS, Andrew, J. , TAO, Zhi-Fu , WANG, Le , WANG, Xilu , DESHAYES, Kurt
IPC分类号: A01N43/00 , C07D417/14 , C07D471/06 , C07D487/04 , C07D513/06 , C07D495/04 , C07D473/00 , C07D513/04
CPC分类号: C07D417/14 , C07D471/06 , C07D473/00 , C07D487/04 , C07D495/04 , C07D513/04 , C07D513/06
-
3.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 有权
标题翻译: 凋亡诱导剂治疗癌症和免疫和自身免疫性疾病公开(公告)号:EP2376197B1
公开(公告)日:2017-02-15
申请号:EP09768289.2
申请日:2009-12-04
发明人: BRUNCKO, Milan , DAI, Yujia , DING, Hong , DOHERTY, George, A. , ELMORE, Steven, W. , HASVOLD, Lisa , HEXAMER, Laura , KUNZER, Aaron, R. , MANTEI, Robert, A. , MCCLELLAN, William, J. , PARK, Chang, H. , PARK, Cheol-Min , PETROS, Andrew, M. , SONG, Xiaohong , SOUERS, Andrew, J. , SULLIVAN, Gerard, M. , TAO, Zhi-Fu , WANG, Gary, T. , WANG, Le , WANG, Xilu , WENDT, Michael, D. , CZABOTAR, Peter Edward , LESSENE, Guillaume Laurent , COLMAN, Peter Malcom
IPC分类号: A61P35/00 , A61K31/496 , C07D403/12
CPC分类号: C07D405/12 , C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D295/30 , C07D309/04 , C07D401/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
-
4.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
标题翻译: APOPTOSEINDUKTOREN ZUR BEHANDLUNG冯KREBS SOWIE VON IMMUN- UND AUTOIMMUNERKRANKUNGEN公开(公告)号:EP3112361A1
公开(公告)日:2017-01-04
申请号:EP16175661.4
申请日:2009-12-04
发明人: BRUNCKO, Milan , DAI, Yujia , DING, Hong , DOHERTY, George, A. , ELMORE, Steven, W. , HASVOLD, Lisa , HEXAMER, Laura , KUNZER, Aaron, R. , MANTEI, Robert, A. , MCCLELLAN, William, J. , PARK, Chang, H. , PARK, Cheol-Min , PETROS, Andrew, M. , SONG, Xiaohong , SOUERS, Andrew, J. , SULLIVAN, Gerard, M. , TAO, Zhi-Fu , WANG, Gary, T. , WANG, Le , WANG, Xilu , WENDT, Michael, D. , CZABOTAR, Peter Edward , LESSENE, Guillaume Laurent , COLMAN, Peter Malcom
IPC分类号: C07D401/14 , C07D405/14 , C07D213/74 , C07D309/04 , C07D213/84 , C07D235/06 , C07D405/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D277/24 , C07D209/08 , C07D211/58 , C07D295/30 , A61P35/00 , A61K31/496 , C07D231/56
CPC分类号: C07D405/12 , C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D295/30 , C07D309/04 , C07D401/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
摘要: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
摘要翻译: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有化合物的组合物和治疗其中表达抗凋亡Bcl-2蛋白的疾病的方法。
-
公开(公告)号:EP1682555A1
公开(公告)日:2006-07-26
申请号:EP04800653.0
申请日:2004-11-03
申请人: ABBOTT LABORATORIES
发明人: TAO, Zhi-Fu , LIN, Nan-Horng , WANG, Le , SOWIN, Thomas, J. , SULLIVAN, Gerard, M. , TONG, Yunsong , PRZYTULINSKA, Magdalenna , LI, Gaoquan
IPC分类号: C07D498/08 , C07D498/18 , A61K31/4995 , A61K31/395 , A61P35/00
CPC分类号: C07D498/08 , C07D498/18
摘要: Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds
-
公开(公告)号:EP1339695B1
公开(公告)日:2006-04-19
申请号:EP01273519.7
申请日:2001-11-30
申请人: ABBOTT LABORATORIES
发明人: CLAIBORNE, Akiyo, K. , GWALTNEY, Stephen, L, II , HASVOLD, Lisa, A. , LI, Qun , LI, Tomgmei , LIN, Nan-Horng , MANTEI, Robert, A. , ROCKWAY, Todd, W. , SHAM, Hing, L. , SULLIVAN, Gerard, M. , TONG, Yunsong , WANG, Gary, T. , WANG, Le , WANG, Xilu , WANG, Weibo
IPC分类号: C07D233/64 , A61K31/4164 , C07D401/12 , A61P35/00
CPC分类号: C07D233/64 , C07D401/12 , C07D405/12 , C07D409/12
摘要: Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
摘要翻译: 具有式(I)的取代的咪唑和噻唑可用于抑制法尼基转移酶。 还公开了法尼基转移酶抑制组合物和抑制患者中法尼基转移酶的方法。
-
7.
公开(公告)号:EP1606268A1
公开(公告)日:2005-12-21
申请号:EP04715097.4
申请日:2004-02-26
申请人: ABBOTT LABORATORIES
发明人: HASVOLD, Lisa, A. , HEXAMER, Laura , LI, Gaoquan , LIN, Nan-Horng , SHAM, Hing , SOWIN, Tom , SULLIVAN, Gerard, M. , WANG, Le , XIA, Ping Xia
IPC分类号: C07D243/38 , A61K31/551 , A61P35/00
CPC分类号: C07D243/38 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/06 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/12 , C07D491/10
摘要: Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
8.SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES 有权
标题翻译: 磺酰胺ALS BCL-2选择性的细胞凋亡诱导剂治疗癌症和免疫球蛋白和自身免疫疾病公开(公告)号:EP2507229A1
公开(公告)日:2012-10-10
申请号:EP10727241.1
申请日:2010-06-01
申请人: Abbott Laboratories
发明人: PARK, Chang, H. , BRUNCKO, Milan , DING, Hong , DOHERTY, George A. , ELMORE, Steven, W. , HASVOLD, Lisa , HEXAMER, Laura , KUNZER, Aaron , MANTEI, Robert, A. , McCLELLAN, William, J. , PARK, Cheol-Min , PETROS, Andrew, M. , SONG, Xiaohong , SOUERS, Andrew, J. , SULLIVAN, Gerard, M. , TAO, Zhi-Fu , WANG, Gary, T. , WANG, Le , WANG, Xilu , WENDT, Michael, D. , HANSEN, Todd, M.
IPC分类号: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04 , C07D295/14 , C07D309/14 , C07D401/12 , C07D295/125 , C07D231/56 , C07D405/14
CPC分类号: C07D401/12 , A61K31/407 , A61K31/495 , A61K31/496 , A61K31/501 , A61K31/5377 , A61K45/06 , C07D209/08 , C07D209/32 , C07D211/58 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D241/04 , C07D249/04 , C07D295/125 , C07D295/14 , C07D295/155 , C07D309/04 , C07D309/14 , C07D401/06 , C07D403/06 , C07D405/06 , C07D405/12 , C07D405/14 , C07D413/06 , C07D417/12 , C07D471/04 , C07D487/04
摘要: Disclosed are compounds (I) which inhibit the activity of anti-apoptotic Bc1-2 or Bc1 xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti apoptotic Bc1-2 protein.
-
公开(公告)号:EP1200412B1
公开(公告)日:2003-11-12
申请号:EP00950584.3
申请日:2000-07-21
申请人: Abbott Laboratories
发明人: WANG, Le , LI, Qun , SHAM, Hing L. , WOODS, Keith, W.
IPC分类号: C07D233/54 , A61K31/4164 , A61P35/00
CPC分类号: C07D233/64
摘要: Compounds of formula (I) or a pharmaceutically acceptable salt or prodrug thereof, wherein R1 is selected from the group consisting of hydrogen, methyl, ethyl, propyl, and isolpropyl; and one of R2 or R3 is 3,4,5-trimethoyxphenyl, and the other is phenyl substituted with one, two, or three substitutents independently selected from the group consisting of alkoxy, halo, and -NR4R5, wherein R?4 and R5¿ are independently selected from the group consisting of hydrogen and alkyl, inhibit celluar proliferation. Processes for the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
-
10.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 有权
标题翻译: 细胞凋亡诱导剂治疗癌症和免疫及自身免疫疾病公开(公告)号:EP2507211A1
公开(公告)日:2012-10-10
申请号:EP10722500.5
申请日:2010-06-01
申请人: Abbott Laboratories
发明人: BRUNCKO, Milan , DAI, Yujia , DING, Hong , DOHERTY, George A. , ELMORE, Steven W. , HASVOLD, Lisa , HEXAMER, Laura , KUNZER, Aaron , MANTEI, Robert A. , McCLELLAN, William J. , PARK, Chang H. , PARK, Cheol-Min , PETROS, Andrew M. , SONG, Xiaohong , SOUERS, Andrew J. , SULLIVAN, Gerard M. , TAO, Zhi-Fu , WANG, Gary T. , WANG, Le , WANG, Xilu , WENDT, Michael D. , HANSEN, Todd M.
IPC分类号: C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D309/04 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
CPC分类号: C07D209/08 , A61K31/635 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D295/30 , C07D309/04 , C07D309/08 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
摘要: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
摘要翻译: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有该化合物的组合物和治疗表达抗凋亡Bcl-2蛋白的疾病的方法。
-
-
-
-
-
-
-
-
-